<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T09:55:10Z</responseDate>
  <request identifier="oai:figshare.com:article/33979375" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33979375</identifier>
        <datestamp>2026-09-24T04:31:26Z</datestamp>
        <setSpec>category_374</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Daily consumption of sulfate- and magnesium-rich mineral water enhances bowel function in adults with chronic constipation: a randomized double-blind real-world trial.docx</dc:title>
          <dc:creator>Katharina Mansouri (17688828)</dc:creator>
          <dc:creator>Thierry Hanh (7346483)</dc:creator>
          <dc:creator>Ronja Meyer (25101841)</dc:creator>
          <dc:creator>Andreas Hahn (275151)</dc:creator>
          <dc:subject>Clinical and Sports Nutrition</dc:subject>
          <dc:subject>bowel function</dc:subject>
          <dc:subject>clinical trial</dc:subject>
          <dc:subject>constipation</dc:subject>
          <dc:subject>magnesium</dc:subject>
          <dc:subject>mineral water</dc:subject>
          <dc:subject>sulfate</dc:subject>
          <dc:description>Introduction&lt;p&gt;Functional constipation is one of the most common disorders of gut–brain interaction. Adequate hydration is recommended as first-line therapy, yet evidence regarding the efficacy of sulfate- and magnesium-rich mineral water remains limited. Therefore, this study investigated its efficacy and safety in a nationwide decentralized randomized controlled trial.&lt;/p&gt;Methods&lt;p&gt;In this randomized, double-blind, controlled parallel-group trial, adults with chronic constipation according to the Rome IV criteria consumed either 1 L/day of sulfate- and magnesium-rich mineral water (HSM) or a low-mineralized control water (LSM) for 3 weeks following a one-week run-in period. Participants maintained a total daily fluid intake of at least 1,5L/day. The primary outcome was the change in weekly bowel movement frequency after 3 weeks. Additional analyses were conducted after 2 weeks of intervention. Secondary outcomes included stool consistency, responder rates, time to treatment response, constipation-related symptoms (PAC-SYM), constipation-related quality of life (PAC-QoL), gastrointestinal transit time, laxative use, and safety.&lt;/p&gt;Results&lt;p&gt;After 2 weeks (additional analysis), bowel movement frequency increased significantly more in the HSM group than in the control group (mean change: 1.31 ± 3.24 vs. 0.34 ± 2.49 bowel movements/week; p = 0.043). This effect was more pronounced in participants with moderate-to-severe constipation (p = 0.022). No significant between-group difference was observed at the end of week 3 (p = 0.144). Time to treatment response was significantly shorter with HSM water than with control water (median 9 vs. 16 days; p = 0.042), accompanied by a higher responder rate in participants with moderate-to-severe constipation (p = 0.043). No significant between-group differences were observed for stool consistency, constipation symptoms, quality of life, or gastrointestinal transit time. Both interventions were well tolerated, and only mild transient adverse events were reported.&lt;/p&gt;Discussion&lt;p&gt;Daily consumption of 1 L of sulfate- and magnesium-rich mineral water, combined with adequate hydration, improved bowel movement frequency at week two and accelerated treatment response in adults with chronic constipation, whereas the between-group difference at the registered primary endpoint (week three) was not statistically significant. These findings suggest that sulfate- and magnesium-rich mineral water may serve as a safe, non-pharmacological dietary approach for the management of chronic constipation under real-world conditions.&lt;/p&gt;Clinical trial registration&lt;p&gt;https://clinicaltrials.gov/, DRKS00034871.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-24T04:31:26Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fnut.2026.1924028.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Daily_consumption_of_sulfate-_and_magnesium-rich_mineral_water_enhances_bowel_function_in_adults_with_chronic_constipation_a_randomized_double-blind_real-world_trial_docx/33979375</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
